Aqua Bounty Technologies - Health And Productivity

 

The CompanyTechnology, Frequently Asked QuestionsMediaInvestor Relations Contact Us
Site Map Employment Opportunities

 


 

The Company

AquAdvantage™ Therapeutic Products

Shrimp IMS

Shrimp IMS is a novel protein-based therapeutic feed additive that stimulates the natural immune system of shrimp resulting in significantly enhanced disease resistance. Several years of laboratory evaluations and controlled disease challenges followed by field trials in Thailand, Belize, Ecuador and Mexico demonstrated consistent improvements in survival of farmed shrimp treated with Shrimp IMS. Shrimp IMS functions by stimulating production of haemocytes, the shrimp’s first line of defense against invading disease organisms. In fact, a unique feature of Shrimp IMS that distinguishes it from traditional, first generation immunostimulants is the ability of the end user to evaluate its efficacy by quantifying haemocytes in shrimp haemolymph during the course of the production crop. Empowered with the confidence that the shrimp’s immune defenses are fortified by IMS, farmers are able to prolong their production cycles, even in the presence of disease events, in order to reach the larger, more commercially lucrative market sizes of shrimp.

A controlled field trial conducted in 2004 in four commercial shrimp farms in Mexico convincingly demonstrated to local shrimp farmers the economic benefits of using of Shrimp IMS. Improvements in final survival of ponds protected with IMS ranged from 20% to 46% compared to unprotected ponds across all four farms. This translated to a ROI of $2.41 for every $1 spent on IMS by the shrimp farmer, for an average increase in net income to a typical 200 hectare farm of $136,000 per crop.

Shrimp IMS is delivered to shrimp in hatcheries via commercial larval feeds containing IMS, and to shrimp in ponds via readily available pelleted growout feed containing IMS.

For more information please email: shrimp-products at aquabounty.com

In the Pipeline

VPX Viral Blocker

VPX Viral Blocker is a protein based therapeutic for shrimp that prevents infection by the deadly White Spot virus (WSSV) by effectively blocking entry of the virus into shrimp. WSSV is a catastrophic shrimp disease that is found in almost every country where shrimp is farmed, and which has caused economic losses of billions of dollars in the global shrimp aquaculture industry. The Company has completed laboratory evaluations of VPX, and is currently optimizing a manufacturing system in preparation for field trials in 2006. Laboratory tests with VPX have shown that survival of VPX protected shrimp challenged with WSSV can approach 100%.

For more information please email: shrimp-products at aquabounty.com

AquAdvantage™ Diagnostics

SYBR Shrimp Diagnostic Test Kit

The SYBR Shrimp test kit is one of the most sensitive shrimp disease diagnostic and detection kits currently available in the market place. Using advanced PCR technology, the kit can detect very low levels of up to five of the most common shrimp viruses in as little as two hours. Owing to its ability to detect these viruses at the molecular level, SYBR Shrimp diagnostic kits can provide producers advanced warning for mitigation of crop loss through disease management measures, well in advance of epizootic disease outbreaks. The highly sensitivity nature of the diagnostic kits lends itself to heightened disease surveillance in biosecure production systems where even the smallest presence of disease organisms can reek havoc. SYBR Shrimp diagnostic kits also provide an excellent complement to both VPX and IMS, where a positive test kit diagnosis will encourage use of the therapeutic products in disease management and prevention.

SYBR Shrimp diagnostic kits are flexibly configured for use with both traditional PCR and the newer “real time” quantitative PCR technologies. The latter provides the kit with detection sensitivity that is enhanced over 100 fold compared with the older technologies. It also delivers a more precise and measurable estimate of the pathogen loading in the sample, provides enhanced specificity, and is particularly useful in the detection of rare targets. In fact, the SYBR Shrimp kits are the first aquatic diagnostic tool to work optimally with quantitative PCR. In addition to the White Spot virus (WSSV), up to four additional viruses that affect the shrimp farming industry can be detected, with wider target detection capability.

For more information about SYBR Shrimp diagnostic kits, prices and configurations, or if you would like to place an order email:
kit-info at aquabounty.com

In the Pipeline

Salmon Therapeutics and Diagnostics

Aqua Bounty is developing improved variants of two critical salmon vaccines, a multivalent vaccine for salmon, as well as an antifungal to protect fish eggs in aquaculture settings. As part of its diagnostics laboratory development effort, Aqua Bounty is also developing diagnostics capabilities to detect up to 5 of the most common diseases in salmon.

AquAdvantage™ Broodstock Program

Aqua Bounty is also developing advanced-hybrid salmon, trout, and tilapia broodstock engineered to grow faster than traditional broodstock. AquAdvantage™ fish reach market size twice as fast and convert feed into body mass 10% – 30% more efficiently than traditional broodstock. These improvements provide both a highly compelling economic benefit to farmers (reduced growing cycle, better feed efficiency) as well as benefits to the environment from reduced release of waste products, faster fallowing cycles and potential improvement of the economic viability of inland operations, thereby mitigating the need for more environmentally consequential ocean pens. The fish are also neutered so the threat of interbreeding with native populations, a major recent concern in salmon farming, is avoided.

As demonstrated in the growth chart above, the AquAdvantage™ fish grow faster and reach mature size earlier than standard fish, but they do not grow to be larger. Mature AquAdvantage™ fish are effectively identical and indistinguishable by the consumer in all respects to their conventional counterparts.

Ongoing research is expanding the application of the AquAdvantage™ technology to other finfish and crustaceans and is focused on identifying other desirable traits such as disease resistance and cold tolerance. In shrimp, for example, a “forced-selection” technique has enabled the Company to identify specific genetic markers that correlate with increased growth rates and good health of P. stylirostris, a popular white shrimp.

For more information please email: broodstock at aquabounty.com

   

© 2006 Aqua Bounty Technologies. All Rights Reserved.